Opus Genetics, Inc. (IRD)

Opus Genetics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	59.96	45.09	30.32	50.5	42.63	24.53
Short-Term Investments	-	-	0	0.02	0.05	0.22
Cash & Short-Term Investments	59.96	45.09	30.32	50.52	42.68	24.75
Cash Growth	43.47%	48.70%	-39.97%	18.35%	72.44%	50.94%
Accounts Receivable	2.72	3.17	5.77	2.33	4.85	-
Other Current Assets	3.93	1.79	0.52	1.1	1.45	1.31
Total Current Assets	66.6	50.04	36.61	53.95	48.99	26.07
Net Property, Plant & Equipment	0.19	0.2	0.25	-	0.01	0.01
Total Assets	66.79	50.24	36.86	53.95	48.99	26.08
Accounts Payable	4.42	3.29	3.15	2.15	1.07	1.58
Accrued Expenses	4.92	4.49	8.15	1.82	1.68	1.73
Short-Term Debt	-	-	-	-	-	0.54
Other Current Liabilities	-	-	-	0.07	-	-
Total Current Liabilities	9.34	7.78	11.3	4.04	2.75	3.86
Other Long-Term Liabilities	78.55	27.11	-	-	-	-
Total Long-Term Liabilities	78.55	27.11	-	-	-	-
Total Liabilities	87.89	34.9	11.3	4.04	2.75	3.86
Preferred Stock	24.74	-	-	-	-	-
Common Stock	0.01	0.01	0	0	0	0
Additional Paid-in Capital	208.28	203.93	145.72	131.37	117.72	111.59
Retained Earnings	-254.12	-188.59	-139	-81.47	-71.48	-89.37
Total Common Shareholders' Equity	-21.1	15.35	6.72	49.91	46.24	22.22
Minority Interest	-	-	18.84	-	-	-
Shareholders' Equity	-45.84	15.35	6.72	49.91	46.24	22.22
Total Liabilities & Equity	66.79	50.24	36.86	53.95	48.99	26.08
Total Debt	-	0	0	0	0	0.54
Net Cash (Debt)	59.96	45.09	30.32	50.52	42.68	24.22
Net Cash Growth	32.97%	48.70%	-39.97%	18.35%	76.27%	47.66%
Net Cash Per Share	0.80	0.72	1.14	2.34	2.07	1.63
Book Value	-21.1	15.35	6.72	49.91	46.24	22.22
Book Value Per Share	-0.28	0.25	0.25	2.31	2.24	1.50
Tangible Book Value	-21.1	15.35	6.72	49.91	46.24	22.22
Tangible Book Value Per Share	-0.28	0.25	0.25	2.31	2.24	1.50

Updated May 12, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q